As muscle atrophy has been shown to be induced by upregulated myostatin in aging and various pathological conditions [13,35,36], we sought to examine alterations in the expression of myostatin and NF-κB, as a potential mechanism underlying the muscle atrophy seen in PD, 4 weeks after MPTP/p treatment. Here, NFKB1 is linked to Parkinson disease.